ARKRAY Launches Assure 4 Blood Glucose Monitoring System

Armen Hareyan's picture

Blood Glucose Monitoring System

ARKRAY USA has started to sell its Assure 4 Blood Glucose Monitoring System to the Long Term Care (LTC) market.

ARKRAY USA, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market this system earlier in the year.


Assure 4 is specifically designed for the rigours of use within long-term care (LTC) facilities. This intuitive, easy-to-use system gives results in 10 seconds, requires a 1.5 microliter sample size, and has a 50-count test memory.

The contour design makes the meter easy to hold. The Guide- Me Curve Test Strip guides the finger to the sample application tip for easy testing.

"Our expertise has always been in LTC and we are very excited to launch the Assure 4 Blood Glucose Monitoring System into our core market," said Tawni Sigelmier, Director of Corporate Accounts for ARKRAY USA, Inc. "This system is a significant extension of our Assure 3 Blood Glucose Monitoring System. The enhancements are based on feedback from the large community of healthcare professionals who currently use Assure 3. By adding this product to our LTC portfolio, we are able to give LTC professionals the option of an easy-to-use, intuitive meter in Assure 4 or a full-featured system in Assure Pro."

The Assure 4 Blood Glucose Monitoring System is now available to the LTC market.